Your browser is no longer supported. Please, upgrade your browser.
Settings
PID PowerShares Intl Div Achiev ETF daily Stock Chart
PID [NASD]
PowerShares Intl Div Achiev ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.02%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month3.95%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter4.57%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio0.48 Perf Half Y6.12%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year11.04%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range13.71 - 15.85 Perf YTD9.58%
Dividend0.59 P/FCF- EPS past 5Y- ROI- 52W High-0.38% Beta-
Dividend %3.74% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low15.17% ATR0.13
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)65.20 Volatility0.59% 0.71%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.54 Prev Close15.71
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume229.20K Price15.79
Recom- SMA202.16% SMA502.89% SMA2006.37% Volume122,747 Change0.51%
Jul-25-17 07:39AM  Novartis in 2Q17: Performance of Sandoz Market Realist
Jul-17-17 12:05PM  Analysts Expect Novartiss Revenues to Fall in 2Q17 Market Realist
Jun-13-17 10:36AM  What Makes This Global Dividend Income ETF So Popular Zacks
Jun-01-17 09:09AM  Inside Novartiss Segment-Wise Performance in 1Q17 Market Realist
May-29-17 09:06AM  Performance of Sanofis Established Prescription Products in 1Q17 Market Realist
May-02-17 12:00PM  Don't Sell, Buy 4 High Dividend ETFs Under $20 in May Zacks
09:07AM  How GlaxoSmithKlines Vaccines Business Performed in 1Q17 Market Realist
May-01-17 07:40AM  How GlaxoSmithKlines Business Segments Performed in 1Q17 Market Realist
Apr-27-17 05:05PM  Novartiss 1Q17 Earnings: Innovative Medicines Segment Market Realist
Apr-26-17 07:36AM  GlaxoSmithKlines 1Q17 Estimates: Vaccines Business Market Realist
Apr-24-17 10:37AM  Analyst Ratings and Recommendations for Novartis Market Realist
Apr-21-17 01:13PM  Analyst Estimates for Novartiss 1Q17 Earnings Market Realist
Apr-04-17 07:36AM  Novartis Expects to Restore Alcons Profitability in the Future Market Realist
07:36AM  Novartis Expects to Restore Alcons Profitability in the Future
Apr-03-17 07:37AM  Sanofi Genzyme Continued Growth in 2016 Market Realist
07:37AM  Sanofi Genzyme Continued Growth in 2016
Mar-30-17 10:36AM  Reduced Co-pays May Boost Demand for Entresto Market Realist
10:36AM  Reduced Co-pays May Boost Demand for Entresto
07:36AM  Performance of GlaxoSmithKlines Vaccines Business in 2016 Market Realist
07:36AM  Performance of GlaxoSmithKlines Vaccines Business in 2016
Mar-29-17 07:37AM  GlaxoSmithKlines Pharmaceuticals Segment Performance Market Realist
07:37AM  GlaxoSmithKlines Pharmaceuticals Segment Performance
Mar-28-17 02:56PM  With low yields abroad, investors hunt for international dividend funds MarketWatch
02:56PM  With low yields abroad, investors hunt for international dividend funds at MarketWatch
Mar-27-17 10:37AM  Sandoz: Novartiss Generics Business in 2016 Market Realist
10:37AM  Sandoz: Novartiss Generics Business in 2016
09:08AM  Novartiss Innovative Medicines Segment in 2016 Market Realist
09:08AM  Novartiss Innovative Medicines Segment in 2016
Feb-21-17 10:36AM  What Happened to Sanofis Valuation after 4Q16? Market Realist
10:36AM  What Happened to Sanofis Valuation after 4Q16?
Feb-20-17 07:37AM  This Keeps Driving Sanofis Growth
Feb-16-17 07:35AM  GlaxoSmithKlines Consumer Healthcare Reports Growth in 4Q16
Feb-15-17 10:36AM  GlaxoSmithKlines Vaccines Business Reported Growth in 4Q16
Feb-14-17 01:35PM  4Q16 Performance of GlaxoSmithKlines Business Segments
Feb-01-17 04:35PM  Novartiss Innovative Medicines Segment in 4Q16
Jan-30-17 10:36AM  PotashCorp in 4Q16: Nitrogen Prices Added Salt to the Wound
Jan-23-17 09:07AM  Novartiss 4Q16 Estimates: Innovative Medicines Segment
Jan-17-17 09:06AM  How Did Novartiss Generics Business Perform in 3Q16?
Dec-30-16 09:07AM  How GlaxoSmithKlines Pharmaceuticals Segment Has Performed
Dec-14-16 09:30AM  The Zacks Analyst Blog Highlights: Guggenheim S&P Global Dividend Opportunities Index ETF, PowerShares International Dividend Achievers Portfolio, PowerShares High Yield Equity Dividend Achievers Portfolio and AdvisorShares Athena High Divi
Dec-13-16 11:05AM  4 High Dividend ETFs Under $20
Nov-23-16 04:01PM  PowerShares Announces Listing Transfer for 27 ETFs PR Newswire
Nov-17-16 11:04AM  How Sandoz Performed for Novartis in 3Q16
Nov-03-16 10:04AM  How Tresiba Helps Novo Achieve Its Growth Targets
08:04AM  Victoza Dominates Global GLP-1 Class
Nov-02-16 11:04AM  Reading Novos Insulin Portfolio to Find Clues about Its Growth
Nov-01-16 06:04PM  US Still the Largest Market for Novo Nordisk
08:04AM  Why Did PotashCorps Nitrogen Prices Fall in 3Q16?
Oct-25-16 10:52AM  How Much Is the Return Opportunity for Novo Nordisk in 3Q16?
Oct-24-16 11:04AM  Novartiss 3Q16 Estimates: Will Alcon Recover Its Growth?
08:05AM  Novartiss 3Q16 Estimates: Innovative Medicines Segment
Oct-20-16 09:44AM  5 Best Smart Beta ETFs That Pay Dividends (PID, ICF) at Investopedia
Oct-07-16 01:16PM  Is the Dividend ETF Bull Run Over?
Oct-06-16 09:00AM  International Dividend ETFs Remain Solid Ideas
Oct-03-16 10:04AM  Novo Nordisk Expects to Witness Strong Growth from New Product Launches
Sep-30-16 06:04PM  Novo Nordisk Is Expected to See Strong Growth in Insulin Segment
Sep-29-16 05:04PM  Novo Nordisk Is Focusing on These Strategic Areas in 2016
Sep-28-16 11:04AM  Tevas Share of the US Generics Market Could Boost Its Stock
Sep-26-16 11:05AM  Winning? We Review How Teva Dominates Generic Drug Space
Sep-15-16 11:04AM  Sanofis Chase for Zika Virus Vaccine Could Drive Its Share Price
08:04AM  Will Sanofi See More Growth from Its Blockbuster Insulin Drug?
Sep-13-16 11:04AM  GSK Optimistic about Future of Its Consumer Healthcare Segment
10:04AM  GlaxoSmithKline Giving a Shot to Its Vaccines Business
Sep-12-16 11:04AM  GlaxoSmithKlines Combo Treatment for HIV Faces Stiff Competition
Sep-08-16 12:27PM  5 Undervalued ETFs for Dividend Lovers
11:18AM  Analyzing Sanofis Asset Swap Deal with Boehringer Ingelheim
Aug-22-16 11:04AM  Teva Pharmaceutical: A Successful Bond Financing Program in 2016
11:04AM  How Merial Contributes to Sanofis Growth
Aug-19-16 11:04AM  What Happened to Sanofis Consumer Healthcare and Generics Franchise in 2Q16?
Aug-18-16 11:04AM  Behind Sanofis Diabetes and Cardiovascular Performance in 2Q16
09:06AM  Genzyme Continued to Boost Growth for Sanofi in 2Q16
Aug-17-16 05:05PM  Inside Sanofis Valuation Changes
Aug-09-16 03:40PM  How Did Novo Nordisk Perform across Geographies in 1H16?
Aug-08-16 10:09AM  A New Low Volatility International ETF for Dividend Lovers
10:09AM  A New Low Volatile International ETF for Dividend Lovers
Aug-05-16 11:07AM  An Update on Shires Upcoming Milestones
Aug-02-16 09:07AM  How Did GlaxoSmithKlines Pharmaceuticals Segment Do in 2Q16?
Aug-01-16 04:47PM  How Much Growth Will Novo See in 2Q16?
Jul-30-16 08:40PM  GlaxoSmithKline Increases Top Line in 2Q16
Jul-28-16 09:07AM  What to Expect from Shires Genetic Disease Franchise
Jul-22-16 01:15PM  What Role Did Innovative Medicines Play in Novartiss 2Q16 Earnings?
Jul-21-16 01:49PM  How Did Novartiss 2Q16 Earnings Stand up to Analyst Estimates?
Jul-18-16 09:45AM  Novartiss 2Q16 Earnings: Whats Expected?
Jul-01-16 09:09AM  How Could the Novartis-Xencor Alliance Benefit Novartis?
Jun-30-16 03:54PM  What Is Xencors XmAb Technology?
12:01PM  A New Idea Among International Dividend ETFs
Jun-28-16 09:09AM  Could Novo Nordisks 2016 Earnings Impress Wall Street?
Jun-27-16 12:23PM  Evaluating Novo Nordisks Efficiency Based on EV-to-EBITDA
Jun-24-16 10:35AM  Revisiting An International Dividend ETF -5.34%
Jun-17-16 03:37PM  International ETFs For Investors Looking To Balance Income, Growth
Jun-10-16 03:33PM  6 Best ETF Picks: Investing Nimbly With Some Excitement Thrown In
May-25-16 11:07AM  Major Developments for Sanofi in 1Q16
May-24-16 03:06PM  Sanofis Diabetes and Cardiovascular Franchise Performance
02:04PM  New International Dividend Growth ETF by iShares in Focus
May-20-16 01:04AM  Why PotashCorps Gross Margins Fell in 1Q16
May-19-16 03:45PM  A Peek at Sanofis Valuation Cheat Sheet
May-06-16 12:06PM  Novos Geographical Sales Split in 1Q16
10:13AM  Why Did Agrium Perform Better Than Expected in 1Q16?
May-05-16 10:46AM  Low U.S. Interest Rates Boost International Dividend ETFs
04:07AM  How Did GlaxoSmithKlines Global Pharmaceuticals Business Perform?
The investment seeks investment results that generally correspond (before fees and expenses) to the price and yield of the NASDAQ International Dividend AchieversTM Index. The fund generally will invest at least 90% of its total assets in dividend-paying common stocks and other securities that comprise the underlying index. The underlying index is composed of Global Depositary Receipts ("GDRs") and American Depositary Receipts that are listed on the London Stock Exchange ("LSE") or the London International Exchange, in addition to ADRs and non-U.S. common or ordinary stocks traded on the New York Stock Exchange, the NASDAQ Stock Market LLC or NYSE Arca, Inc.